These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36694845)

  • 1. Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.
    Didden EM; Lee E; Wyckmans J; Quinn D; Perchenet L
    Pulm Circ; 2023 Jan; 13(1):e12188. PubMed ID: 36694845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare databases.
    Didden EM; Lu D; Hsi A; Brand M; Hedlin H; Zamanian RT
    Pulm Circ; 2024 Jan; 14(1):e12333. PubMed ID: 38333073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of claims-based algorithms for pulmonary arterial hypertension.
    Papani R; Sharma G; Agarwal A; Callahan SJ; Chan WJ; Kuo YF; Shim YM; Mihalek AD; Duarte AG
    Pulm Circ; 2018; 8(2):2045894018759246. PubMed ID: 29480064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
    Weiss TJ; Rosen Ramey D; Yang L; Liu X; Patel MJ; Rajpathak S; Bajwa EK; Lautsch D
    BMC Pulm Med; 2022 Oct; 22(1):383. PubMed ID: 36258171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A claims-based, machine-learning algorithm to identify patients with pulmonary arterial hypertension.
    Hyde B; Paoli CJ; Panjabi S; Bettencourt KC; Bell Lynum KS; Selej M
    Pulm Circ; 2023 Apr; 13(2):e12237. PubMed ID: 37287599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension.
    Papademetriou E; Liu X; Beaudet A; Tsang Y; Potluri R; Panjabi S
    J Med Econ; 2023; 26(1):644-655. PubMed ID: 37086091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.
    Heresi GA; Platt DM; Wang W; Divers CH; Joish VN; Teal SA; Yu JS
    BMC Pulm Med; 2017 Apr; 17(1):58. PubMed ID: 28399914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
    Gauthier-Loiselle M; Tsang Y; Lefebvre P; Agron P; Royer J; Bell Lynum KS; Bennett L; Panjabi S
    Curr Med Res Opin; 2022 Jun; 38(6):1019-1030. PubMed ID: 35243952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
    Hong C; Chen R; Hu L; Liu H; Lu J; Zhuang C; Guo W; Wu X; Lin J; Sun X; Tang H; Wang Z; Zhang N; Zheng Z
    Clin Respir J; 2023 Jun; 17(6):536-547. PubMed ID: 37141914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class.
    Dufour R; Pruett J; Hu N; Lickert C; Stemkowski S; Tsang Y; Lane D; Drake W
    J Med Econ; 2017 Nov; 20(11):1178-1186. PubMed ID: 28762848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
    Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis.
    Weiss T; Ramey DR; Pham N; Shaikh NF; Tian D; Zhao X; Near AM; Lautsch D; Nathan SD
    Pulm Circ; 2024 Apr; 14(2):e12390. PubMed ID: 38903484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data.
    Gillmeyer KR; Nunez ER; Rinne ST; Qian SX; Klings ES; Wiener RS
    Chest; 2021 May; 159(5):1986-1994. PubMed ID: 33345949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH).
    DuBrock HM; Germack HD; Gauthier-Loiselle M; Linder J; Satija A; Manceur AM; Cloutier M; Lefebvre P; Panjabi S; Frantz RP
    Pharmacoecon Open; 2024 Jan; 8(1):133-146. PubMed ID: 37980316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.